CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 8-K Event Acquisition or sale completed · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Material agreement · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Exit or restructuring costs
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Delisting notice
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Results of operations
Page 7 of 17 · 336 filings